English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
生物通
3 天
纯化念珠菌抗原治疗寻常疣的随机 IIa 期试验:多剂量方案的安全性 ...
为解决非标准化白色念珠菌抗原治疗寻常疣(verruca vulgaris)时最佳剂量未明确的问题,研究人员开展了使用标准化纯化念珠菌抗原(PCA)治疗寻常疣的研究。结果表明三种给药方案均安全且耐受性良好,0.5 mL 注射单疣清除未治疗疣效果更佳,为临床治疗提供了 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Cory Booker breaks record
Missing soldier found dead
Reveals 'Spider-Man 4' title
Says he’s going deaf, blind
Research grants halted
Wins WI Supreme Court race
Wins Florida House seat
AL out-of-state abortions
US job openings slipped
Malaysia gas pipe explosion
Faces second murder trial
Wins Florida special election
‘Top Gun’ star dies at 65
200+ infected with norovirus
Japan on US auto tariffs
New York cat sanctuary fire
Kornacki exits MSNBC
Staffers accused of abuse
States sue Trump admin
Released from custody
Delays tush push decision
6-year, $170M extension
Wants trial moved to NYC
USDOT offers buyouts
ISR strike kills 4 in Beirut
EC approves RSV vaccine
Myanmar death toll climbs
Arizona school bus crash
NBA suspends five players
Webby Awards nominations
Life-threatening flood risk
Sues two pharmacies
US manufacturing shrinks
反馈